Bd Zadine 300 mg Tablet
Brand Name: BD-Zadine
Molecule: Azacitidine
Strength: 300 mg
Quantity: 14 Tablets
Form: Tablet
Packaging Type: Bottle
Manufacturer/Marketed By: BDR Pharma
Country of Origin: India
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
Description
BD Zadine 300 mg Tablet is a prescription medicine containing Azacitidine, a hypomethylating agent used to treat disorders where the bone marrow does not produce healthy blood cells. It is commonly prescribed for myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and selected cases of acute myeloid leukemia (AML). The medicine helps reduce transfusion needs, supports healthy cell production, and slows disease progression.
Benefits
-
Improves production of healthy blood cells
-
Reduces dependence on blood transfusions
-
Slows progression of bone marrow disorders
-
Enhances survival and quality of life
-
Convenient oral alternative to injectable azacitidine
Indications and Usage
BD Zadine 300 mg Tablet is indicated for:
-
Myelodysplastic Syndromes (MDS)
-
Chronic Myelomonocytic Leukemia (CMML)
-
Acute Myeloid Leukemia (AML) (specific patient groups)
-
Patients with abnormal, ineffective, or reduced blood cell production
How it Works
Azacitidine reduces abnormal DNA methylation, restoring normal functioning of bone marrow cells. This slows the growth of immature or cancerous cells and supports healthier blood formation.
Dosage & Administration
-
Dose is customized by the treating oncologist
-
Swallow the tablet whole with water
-
Take exactly as per prescribed treatment cycles
-
Do not crush, chew, or break the tablet
-
Regular blood tests required to monitor safety and response
-
Do not skip or stop treatment without medical advice
Side Effects
Common side effects:
-
Fatigue, weakness
-
Nausea, vomiting
-
Constipation or diarrhea
-
Loss of appetite
-
Low blood counts (anemia, neutropenia, thrombocytopenia)
Serious side effects (seek urgent care):
-
Fever or signs of infection
-
Unusual bleeding or bruising
-
Severe abdominal pain
-
Kidney or liver dysfunction
-
Severe allergic reactions
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
Increased risk of infection due to low immunity
-
Use cautiously in patients with kidney or liver disease
-
Avoid contact with sick individuals
-
Report immediately:
-
Fever or chills
-
Unusual bleeding
-
Yellowing of skin or eyes
-
Chest pain or breathing difficulty
-
-
Inform doctor about all chemotherapy or immunosuppressive drugs being used
Related Products
Related Posts:
Bone Marrow Transplant: A Complete Guide for Patients
The realization that you or someone close to you needs a bone marrow transplant can be extremely daunting. It may
READ MORE »June 16, 2026
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »May 18, 2026
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »May 14, 2026
Only logged in customers who have purchased this product may leave a review.
Reviews
Clear filtersThere are no reviews yet.